Understanding and establishing a link between the physicochemical characteristics of
nanoparticles (NPs) and their biological interactions poses to be a great challenge in the …

Breast cancer is a multifaceted, heterogeneous disease that manifests in the mammary
gland. According to the WHO, more than 2.3 million cases are diagnosed each year, making …

Today, a growing number of computational aids and simulations are shaping model-
informed drug development. Artificial intelligence, a family of self-learning algorithms, is only …

Pharmacometric analysis is often used to quantify the differences and similarities between
formulation prototypes. In the regulatory framework, it plays a significant role in the …

Helicobacter pylori (H. pylori) is a recalcitrant pathogen, which can cause gastric disorders.
During the past decades, polypharmacy‐based regimens, such as triple and quadruple …

Intravenous iron-carbohydrate complexes are nanomedicines that are commonly used to
treat iron deficiency and iron deficiency anemia of various etiologies. Many challenges …

Predictive performance assays are crucial for the development and approval of
nanomedicines and their bioequivalent successors. At present, there are no established …

For decades, there has been a growing interest in injectable subcutaneous formulations to
improve the absorption of drugs into the systemic circulation and to prolong their release …

Complex injectable drug products (CIDPs) have often been developed to modulate the
pharmacokinetics along with efficacy for therapeutic agents used for remediation of chronic …

Abstract Polylactide‐co‐glycolide (PLG) nanoparticles hold immense promise for cancer
therapy due to their enhanced efficacy and biodegradable matrix structure. Understanding …